No Data
No Data
APT Medical's H1 Profit Rises 33%, Operating Income Climbs 27%; Shares Drop 3%
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Southwest Securities: How to view the investment opportunities and challenges of high-value consumables in the post-medicine group purchase era?
In the context of centralized procurement, most areas in the high-value consumables field are currently highly competitive and have limited growth potential. Therefore, the tracks with low penetration rates and low localization rates have long-term growth potential.
Is APT Medical (SHSE:688617) Using Too Much Debt?
APT Medical Gets Registration Certificate for Catheter
No Data